Ambu Acclaimed by Frost & Sullivan for Its Groundbreaking Single-use Flexible Endoscopes
Ambu's customer-focused innovations and use of advanced technologies help the company address market needs in a wide range of applications
SANTA CLARA, Calif., March 2, 2021 /PRNewswire/ -- Based on its recent analysis of the global flexible single-use endoscope market for advanced visualization, Frost & Sullivan recognizes Ambu A/S with the 2021 Global New Product Innovation Award. Ambu provides customers with a full spectrum of single-use devices for in-hospital and out-of-hospital settings, all while optimizing workflow, reducing costs, and improving patient care. The company created the world's first single-use flexible endoscope in 2009 and has used this experience to launch five new single-use endoscopy products for ENT, urology, and gastroenterology segments. The company has announced that it will quadruple its innovation pipeline to launch more than 20 new flexible endoscopy products over the next three years.
Click here to view the full multimedia release: https://bit.ly/3kwN3wC
Ambu's industry-leading technology addresses the traditional challenge of expanding endoscopy procedures while ensuring the devices are safe, affordable, and accessible. Its single-use flexible endoscopes are sterile and patient-ready out of the package, eliminating the risk of patient cross-contamination. Importantly, its innovative platform—with its aView and aBox all-in-one video displays—does away with the traditional video endoscopy tower size and expense. By combining multiple single-use endoscopes with versatile displays, hospitals can own a cost-efficient, compact, and portable platform.
"The aScope™ 4 Broncho portfolio features three sizes of bronchoscopes, ensuring clinicians have a suitable instrument for any of the varying ICU and OR procedures enabled by the aScope™. The aScope™ 4 Broncho can also be utilized with the company's proprietary integrated sampling system, the BronchoSampler, which is a safe, one-handed, one-clinician alternative for specimen sampling," said Pavel Zhebrouski, Best Practices Research Analyst. "Ambu looks to differentiate its device from reusable solutions while also adhering to strict reliability and quality standards of the CE and the US FDA and adapting to growing market demands for innovation."
Ambu's unparalleled supply chain prowess allows it to meet the demand surge, making it a reliable partner to hospitals during this period of uncertainty. The company has caused an innovation paradigm shift in endoscopy by rapidly accelerating the introduction of technologies with shorter product life cycles. It has also outperformed competitors with a focus on innovation and high-scale, low-cost manufacturing. Ambu is now developing its fifth-generation bronchoscope, innovating and improving every new iteration, and taking advantage of the rapid technology advancements within image sensors, materials, AI, and image enhancement.
"A vital part of Ambu's success is building strong and cooperative relationships with its customers and partners. It is on contract with all four major group purchasing organizations in the US. Its recent contract expansions gave 90% of US hospitals access to Ambu's complete line of single-use endoscopes while 98% of US hospitals have access to Ambu's rhinolaryngoscopes, bronchoscopes, and cystoscopes," noted Zhebrouski. "Ambu emphasizes building trust and credibility in the medical community and ensuring high-quality outcomes."
Each year, Frost & Sullivan presents this award to the company that develops an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased return on investment (ROI) it gives customers, which, in turn, raises customer acquisition and overall market penetration potential.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact us: Start the discussion.
Contact:
Bianca Torres
P: 1.210.477.8418
E: bianca.torres@frost.com
About Ambu A/S
Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring & diagnostics solutions. The manifestations of our efforts have ranged from early innovations like the Ambu® Bag™ resuscitator and the Ambu® BlueSensor™ electrodes to our newest landmark solutions like the Ambu® aScope™ – the world's first single-use flexible endoscope. Moreover, we continuously look to the future with a commitment to deliver innovative quality products that have a positive impact on the work of doctors, nurses and paramedics. Headquartered near Copenhagen in Denmark, Ambu employs approximately 4,000 people in Europe, North America and the Asia Pacific. For more information, please visit ambu.com or ambuUSA.com.
Contact:
U.S. media
NorthAmerica-PR@ambu.com
Ambu Inc., 6230 Old Dobbin Lane, Suite 250, Columbia, Maryland, 21045, United States, www.ambuusa.com
European and APAC media
Mikkel Trier Wagner, Director Corporate Communications, tel. +45 4191 0830, email: mtw@ambu.com
Ambu A/S, Baltorpbakken 13, 2750 Ballerup, Denmark, Tel. +45 7225 2000, CVR no.: 63 64 49 19, www.ambu.com
Share this article